RXO (NYSE:RXO) Receives “Hold” Rating from Benchmark

Benchmark reiterated their hold rating on shares of RXO (NYSE:RXOFree Report) in a research report sent to investors on Tuesday, Benzinga reports.

Other research analysts have also issued research reports about the company. Oppenheimer reissued an outperform rating and set a $31.00 price target on shares of RXO in a research note on Tuesday, September 17th. Susquehanna reduced their price target on RXO from $20.00 to $16.00 and set a negative rating on the stock in a research note on Thursday, September 26th. Morgan Stanley increased their price target on RXO from $19.00 to $26.00 and gave the stock an equal weight rating in a research note on Monday, August 12th. TD Cowen increased their price target on RXO from $23.00 to $28.00 and gave the stock a hold rating in a research note on Thursday, August 8th. Finally, UBS Group increased their price target on RXO from $22.00 to $31.00 and gave the stock a neutral rating in a research note on Thursday, August 8th. Two equities research analysts have rated the stock with a sell rating, nine have issued a hold rating and four have assigned a buy rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of Hold and a consensus price target of $26.23.

Read Our Latest Analysis on RXO

RXO Price Performance

RXO stock opened at $29.14 on Tuesday. RXO has a 1 year low of $16.94 and a 1 year high of $32.82. The company has a debt-to-equity ratio of 0.64, a quick ratio of 1.17 and a current ratio of 1.17. The stock’s 50 day moving average price is $27.76 and its 200 day moving average price is $24.80. The firm has a market cap of $3.43 billion, a P/E ratio of -323.78, a PEG ratio of 12.47 and a beta of 1.34.

RXO (NYSE:RXOGet Free Report) last posted its earnings results on Wednesday, August 7th. The company reported $0.03 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.03. RXO had a positive return on equity of 2.22% and a negative net margin of 0.55%. The firm had revenue of $930.00 million for the quarter, compared to analyst estimates of $934.14 million. During the same quarter in the prior year, the company earned $0.08 EPS. RXO’s revenue was down 3.4% on a year-over-year basis. On average, sell-side analysts expect that RXO will post 0.15 earnings per share for the current fiscal year.

Institutional Trading of RXO

Large investors have recently added to or reduced their stakes in the stock. GAMMA Investing LLC increased its holdings in RXO by 40.0% in the 3rd quarter. GAMMA Investing LLC now owns 1,784 shares of the company’s stock valued at $50,000 after purchasing an additional 510 shares in the last quarter. Motco increased its holdings in RXO by 5,450.0% in the 1st quarter. Motco now owns 2,442 shares of the company’s stock valued at $53,000 after purchasing an additional 2,398 shares in the last quarter. Allspring Global Investments Holdings LLC increased its holdings in RXO by 2,235.3% in the 1st quarter. Allspring Global Investments Holdings LLC now owns 3,643 shares of the company’s stock valued at $80,000 after purchasing an additional 3,487 shares in the last quarter. Canada Pension Plan Investment Board acquired a new stake in RXO in the 2nd quarter valued at $112,000. Finally, PNC Financial Services Group Inc. increased its holdings in RXO by 62.2% in the 4th quarter. PNC Financial Services Group Inc. now owns 5,181 shares of the company’s stock valued at $121,000 after purchasing an additional 1,987 shares in the last quarter. 92.73% of the stock is currently owned by institutional investors and hedge funds.

RXO Company Profile

(Get Free Report)

RXO, Inc provides full truckload freight transportation brokering services. It also offers brokered services for managed transportation, last mile, and freight forwarding. The company was incorporated in 2022 and is based in Charlotte, North Carolina.

Featured Stories

Analyst Recommendations for RXO (NYSE:RXO)

Receive News & Ratings for RXO Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RXO and related companies with MarketBeat.com's FREE daily email newsletter.